We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Advertising
The TGA regulates advertisements for therapeutic goods. You need to know if that includes the product you intend to advertise.
Advertising non-compliance reports and investigation outcomes
Latest alerts
-
Robust Extreme capsules pose a serious risk to your health and should not be taken.
-
The TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
-
The TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
Latest articles
-
Sunshine Coast business fined over $37k for alleged unlawful sale of vapes
We have issued infringement notices totalling $37,560 for the alleged unlawful possession of a commercial quantity of vaping goods. -
TGA and InstantScripts reach settlement
The TGA has settled judicial review proceedings brought by InstantScripts in respect of infringement notices issued to it by the TGA. -
TGA warns advertising prescription-only weight-loss medicine is prohibited
The TGA reminds businesses and media outlets that it is unlawful to publicly advertise prescription-only medicines, including prescription-only weight loss medicines.
Latest publications
-
Communique from the meeting of the TGACC
-
This plan outlines the compliance and education priorities of the Therapeutic Goods Administration for 2024.
-
Communique from the meeting of the TGACC